Testing for causality between systematically identified risk factors and glioma: a Mendelian randomization study.

A E Howell1, J W Robinson1, R E Wootton2,3,4

  • 1Brain Tumour Research Centre, Institute of Clinical Neurosciences, University of Bristol, Bristol, UK.

BMC Cancer
|June 5, 2020
PubMed
Summary

Mendelian randomization identified four traits causally linked to increased glioma risk: longer leukocyte telomere length, allergy, alcohol consumption, and extreme childhood obesity. Two traits, LDL cholesterol and triglycerides, reduced non-glioblastoma risk.

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
8.7K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.1K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
576